GHTM

Global Health and Tropical Medicine

  • GHTM
    • About GHTM
    • Governance
    • Impact
    • Members
      • Population health, policies and services
        • PPS PhD members
        • PPS non PhD members
      • TB, HIV and opportunistic diseases and pathogens
        • THOP PhD members
        • THOP non PhD members
      • Vector-borne diseases
        • VBD PhD members
        • VBD non PhD members
      • Individual Health Care
        • IHC PhD members
        • IHC non PhD members
      • Tech & Admin support
    • Scientific Advisory Board
  • Research
    • Cross-cutting issues
      • Global Pathogen Dispersion and Population Mobility
      • Drug Discovery and Drug Resistance
      • Diagnostics
      • Public Health Information
      • Fair Research Partnerships
    • Research Groups
      • PPS – Population health, policies and services
      • THOP – TB, HIV and opportunistic diseases and pathogens
      • VBD – Vector borne diseases
      • IHC – Individual health care
    • Research in numbers
      • 2023
      • 2022
      • 2021
      • 2020
      • 2019
      • 2018
      • 2017
    • Projects
      • Ongoing Projects
      • Completed Projects
  • Outreach
    • Events
    • News
    • Policy Support & Community Outreach
  • Publications
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
  • Capacity Building
    • Education
      • Master Theses
      • PhD Theses
    • International
  • Infrastructures
  • Networks & Partnerships
  • Reports
    • GHTM
    • Scientific Advisory Board
    • FCT
Home / Publications / A review of regional drug strategies across the world: How is prevention perceived and addressed?

A review of regional drug strategies across the world: How is prevention perceived and addressed?

  • Authors: Ballotta D, Carrá G, Dias S, Ferri M
  • Publication Year: 2015
  • Journal: Drugs: Education Prevention and Policy
  • Link: https://www.tandfonline.com/doi/abs/10.3109/09687637.2015.1041456%20

Regional drug strategies and action plans are intergovernmental policy documents that address drug-related problems. This article analyses six of these strategies, involving 148 countries in four continents. We focus in particular on how the prevention of drug-related problems is described, and if a comprehensive approach (such as environmental prevention) is used. All the documents include prevention as one of their key priorities, and three of them provide a comprehensive framework for preventive strategies that incorporates environmental interventions. The European Union drugs strategy explicitly mentions environmental prevention intervention as one of the mutually reinforcing measures for drug demand reduction. Several factors could benefit from wider adoption of an environmental prevention approach. Two of these, both prominent issues, are: the need to promote integration and synergy in efforts to reduce people’s exposure to illicit drugs and the demand for drugs; and the change in the legal status of some traditionally illicit drugs that is occurring in some regions. In terms of the new legal status of some drugs, while it is not yet clear what the possible effects are of the availability and prevalence of use of those substances, prevention is expected to remain an important strategy. The “global strategies” approach can be an important endorsement in achieving wide recognition and the adoption of environmental prevention strategies in drug policy.

Share this:

  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to print (Opens in new window) Print

About GHTM

GHTM is a R&D Unit that brings together researchers with a track record in Tropical Medicine and International & Global Health. It aims at strengthening Portugal's role as a leading partner in the development and implementation of a global health research agenda. Our evidence-based interventions contribute to the promotion of equity in health and to improve the health of populations.

Contacts

Rua da Junqueira, 100
1349-008 Lisboa
Portugal

+351 213 652 600

  • E-mail
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Map

  • Events
  • Research Groups
  • Cross-cutting issues
© Copyright 2025 IHMT-UNL All Rights Reserved.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    UIDB/04413/2020
    UIDP/04413/2020

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok